Timing of surgery and 1‐year postoperative outcomes in patients with breast cancer and preoperative COVID‐19 history: A matched, longitudinal, ambidirectional cohort study

Documenti analoghi

• Clinical outcomes of coronavirus disease in patients with breast cancer treated with granulocyte colony‐stimulating factor following chemotherapy: Triangulation of evidence using population‐based cohort and Mendelian randomization analyses
  di: Yali Wang, et al.
  Pubblicazione: (2024)
• Identification of sequence polymorphism in the D‐loop region of mitochondrial DNA as a risk factor for breast cancer
  di: Qian Nie, et al.
  Pubblicazione: (2024)
• Feasibility and accuracy of targeted axillary dissection by carbon tattooing in biopsy‐proven node‐positive breast cancer: A prospective study
  di: Minyan Chen, et al.
  Pubblicazione: (2025)
• The evolution and prognostic impact of HER2‐low, HER2‐ultralow, and HER2‐null status in HER2‐negative early breast cancer: A pre– to post–neoadjuvant chemotherapy study
  di: Yibin Qiu, et al.
  Pubblicazione: (2026)
• Reply to “Design–analysis mismatch in the analysis of longitudinal HER2 data in breast cancer”
  di: Fangmeng Fu
  Pubblicazione: (2026)